HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost
Objectives: Italy was the first European country to introduce universal vaccination of adolescents, for both males and females, against Human Papilloma Virus (HPV) starting in 2017 with the NIP 2017–2019′s release. However, vaccine coverage rates (VCRs) among adolescents have shown a precarious take...
Main Authors: | Francesco Saverio Mennini, Andrea Silenzi, Andrea Marcellusi, Michele Conversano, Andrea Siddu, Giovanni Rezza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/7/1133 |
Similar Items
-
Exploring uncertainty and use of real-world data in the National Institute for Health and Care Excellence single technology appraisals of targeted cancer therapy
by: Jiyeon Kang, et al.
Published: (2022-12-01) -
HPV infection and breast cancer risk: insights from a nationwide population study in Taiwan
by: Chuck Lin, et al.
Published: (2023-07-01) -
The Right Choice for Production Patterns to Minimize Cost of Incremental
by: Erick Wijaya, et al.
Published: (2011-05-01) -
NeuroBlu: a natural language processing (NLP) electronic health record (EHR) data analytic tool to generate real-world evidence in mental healthcare
by: R. Patel, et al.
Published: (2022-06-01) -
Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016
by: Julia I. Drake, et al.
Published: (2017-01-01)